Background The cumulative risk of a false positive result of a breast-cancer screening test is
unknown. Methods We performed a 10-year retrospective cohort study of breast-cancer …

Background : Over the past 30 years, eight major randomized controlled trials of breast
cancer screening— with mammography and/or clinical breast examination— have been …

ContextBreast cancer screening in community practices may be different from that in
randomized controlled trials. New screening modalities are becoming available.ObjectivesTo …

ContextThe clinical breast examination (CBE) is widely recommended and practiced as a
tool for breast cancer screening; however, its effectiveness is dependent on its precision and …

Mammographic Screening for Breast Cancer | NEJM Skip to main content NEJM Group Follow
Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your …

Peer reviewers are blinded sometimes to authors' and institutions' names, but the effects of
blinding on review quality are not known. We, therefore, conducted a randomized trial of …

Purpose We investigated the efficacy of contralateral prophylactic mastectomy (CPM) in
reducing contralateral breast cancer incidence and breast cancer mortality among women …

APPROXIMATELY 38% OF POSTMENOPAUSAL WOMEN in the United States use
hormone replacement therapy. 1 In 2000, 46 million prescriptions were written for Premarin (…

Background: Few data exist about visits to primary care clinicians for breast symptoms in the
United States. Objective: To determine how often women present with breast symptoms, …

Background: The cumulative risk of a false-positive mammogram can be substantial. We
studied which variables affect the chance of a false-positive mammogram and estimated …